Policy, Talent Pool, And Supply Chain Challenges In Biopharmaceuticals

Source: Cytiva
Scientists In Lab GettyImages-1354171846

How is the state of the industry being affected by government policies, talent pools, and supply chain constraints? Hear from Dave Tudor, Managing Director of Pharma, HealthTech, and Quality at CPI, a division of the UK's High Value Manufacturing Catapult, to gain valuable insight into this matter. Learn about the UK biopharmaceutical industry’s biggest strengths and greatest challenges, how the UK government can take action to help the industry thrive, what must be done to safeguard the future of the industry, and more.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Biosimilar Development